- Home
- ATXS vs AMAL Comparison
ATXS vs AMAL Comparison
Compare ATXS & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AMAL
- Stock Information
- Founded
- ATXS 2008
- AMAL 1923
- Country
- ATXS United States
- AMAL United States
- Employees
- ATXS N/A
- AMAL N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- ATXS Health Care
- AMAL Finance
- Exchange
- ATXS Nasdaq
- AMAL Nasdaq
- Market Cap
- ATXS 676.1M
- AMAL 760.6M
- IPO Year
- ATXS 2015
- AMAL 2018
- Fundamental
- Price
- ATXS $12.46
- AMAL $28.59
- Analyst Decision
- ATXS Buy
- AMAL Hold
- Analyst Count
- ATXS 7
- AMAL 2
- Target Price
- ATXS $30.00
- AMAL $33.00
- AVG Volume (30 Days)
- ATXS 4.1M
- AMAL 173.6K
- Earning Date
- ATXS 11-12-2025
- AMAL 10-23-2025
- Dividend Yield
- ATXS N/A
- AMAL 1.98%
- EPS Growth
- ATXS N/A
- AMAL N/A
- EPS
- ATXS N/A
- AMAL 3.32
- Revenue
- ATXS N/A
- AMAL $306,912,000.00
- Revenue This Year
- ATXS N/A
- AMAL $9.82
- Revenue Next Year
- ATXS N/A
- AMAL $11.11
- P/E Ratio
- ATXS N/A
- AMAL $8.53
- Revenue Growth
- ATXS N/A
- AMAL 1.28
- 52 Week Low
- ATXS $3.56
- AMAL $25.03
- 52 Week High
- ATXS $12.55
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- ATXS 84.72
- AMAL 59.97
- Support Level
- ATXS $11.83
- AMAL $26.03
- Resistance Level
- ATXS $12.16
- AMAL $27.79
- Average True Range (ATR)
- ATXS 0.36
- AMAL 0.82
- MACD
- ATXS 0.26
- AMAL 0.21
- Stochastic Oscillator
- ATXS 97.97
- AMAL 97.26
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.